SAIK ANDREW (Chief Financial Officer) received a stock award from PDS BIOTECHNOLOGY CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2020ACC: 0001140361-20-003645
Officer· Chief Financial Officer
Since Aug 2018
+38.40K
Net shares
Net buyer
$49.9K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
38.40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+38.40K
Price / share
$1.30
Trade value
$49.92K
% of position
925.5%
2/14/2020
4.15K→42.55K
Total
Net shares
+38.40K
Net value
$49.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/14/2020 | A · Award | +38.40K | $1.30 | $49.92K | 925.5% | 4.15K | 42.55K |
| Total | +38.40K | $49.92K | ||||||
Derivative Transactions0
No derivative transactions reported